Dopascan imaging agent that measures the number of dopamine neurons: Will start a Phase I trial; a Phase II trial is ongoing under a physician-sponsored IND

Guilford Pharmaceuticals Inc.

Read the full 38 word article

How to gain access

Continue reading with a
two-week free trial.